Contrast-induced acute kidney injury: How much contrast is safe?

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1376-1383

  Keaney, John J ^a   Hannon, Claire M ^a   Murray, Patrick T ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Acute kidney injury; Contrast media; Contrast ratio; Coronary angiography

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; SODIUM CHLORIDE;

ACCIDENT PREVENTION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CONTRAST RATIO; CORONARY ANGIOGRAPHY;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; GLOMERULAR FILTRATION RATE; HUMANS; RISK FACTORS;

EID: 84879852027     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs602     Document Type: Review

References (47)

1. Bartls ED, Brun GC, Gammeltoft A et al. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scanda 1954; 150: 297-302
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936
3. Stolker JM, McCullough PA, Rao S. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol 2010; 55: 1433-1440
4. Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38: 292-299.
5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494
6. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785
7. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relations to mortality. Am J Med 1997; 103: 368-375
8. Subramanian S, Tumlin J, Bapat B. Economic burden of contrastinduced nephropathy: implications for prevention strategies. J Med Eco 2007; 10: 119-134
9. Sendeski MM. The pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38: 292-299
10. Sendeski M, Patzak A, Pallone TL et al. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast mediuminduced nephropathy. Radiology 2009; 251: 697-704
11. Hsu YC, Nomura S, Krus CW. Some bactericidal and virucidal properties of iodine not affecting infectious RNA and DNA. Am J Epidemiol 1965; 82: 317-328
12. Fanning NF, Manning BJ, Buckley J et al. Iodinated contrast media induce neutrophil apoptosis through a mitochondrial and caspase mediated pathway. Br J Radiol 2002; 75: 861-873
13. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol 2010; 6: 679-688
14. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 14-22
15. Wijns W, Kolh P, Danchin N et al. European association for percutaneous cardiovascular interventions. guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-2555.
16. Kidney Disease: Improving Global Outcomes (KDIGO). Acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2: 1-138
17. Levine GN, Bates ER, Blankenship JC et al. ACCF/AHA/SCAI Guideline For Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58: e44-122
18. Katzberg RW, Lamba R. Contrast-induced nephropathy after intravenous administration: fact or fiction? Radiol Clin North Am 2009; 47: 789-800
19. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264
20. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
21. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-178
22. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261
23. Jo SH, Youn TJ, Koo BK et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006; 48: 924-930
24. McCullough PA, Bertrand ME, Brinker JA et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with lowosmolar contrast media. J Am Coll Cardiol 2006; 48: 692-699
25. Solomon RJ, Natarajan MK, Doucet S et al. Investigators of the CARE Study. Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrastinduced nephropathy in patients with chronic kidney disease. Circulation 2007; 115: 3189-3196
26. Reed M, Meier P, Tamhane UU et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a metaanalysis of randomized controlled trials. JACC Cardiovasc Interv 2009; 2: 645-654
27. Bolognese L, Falsini G, Schwenke C et al. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the contrast media and nephrotoxicity following primary angioplasty for acute myocardial infarction[CONTRAST-AMI] Trial). Am J Cardiol 2012; 109: 67-74
28. Heinrich MC, HÄberle L, Müller V et al. Nephrotoxicity of isoosmolar iodixanol compared with nonionic low-osmolar contrast media: metaanalysis of randomized controlled trials. Radiology 2009; 250: 68-86
29. Nayak KR, Mehta HS, Price MJ et al. A novel technique for ultralow contrast administration during angiography or intervention. Catheter Cardiovasc Interv 2010; 75: 1076-1083
30. Manske CL, Sprafka JM, Strony JT et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620
31. Laskey WK, Jenkins C, Selzer F et al. NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50: 584-590
32. Brown JR, Robb JF, Block CA et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 2010; 3: 346-350
33. Chertow GM, Normand SL, McNeil BJ. 'Renalism': inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 2004; 15: 2462-2468
34. Cigarroa RG, Lange RA, Williams RH et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-652
35. Mason RA, Arbeit LA, Giron F. Renal dysfunction after arteriography. JAMA 1985; 253: 1001-1004
36. Swartz RD, Rubin JE, Leeming BW et al. Renal failure following major angiography. Am J Med 1978; 65: 31-37
37. Older RA, Miller JP, Jackson DC et al. Angiographically induced renal failure and its radiographic detection. Am J Radiol 1976; 126: 1039-1045
38. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Radio1 1981; 136: 859-861
39. Gomes AS, Baker JD, Martin-Paredero V et al. Acute renal dysfunction after major arteriography. Am J Radio1 1985: 145: 1249-1253
40. Freeman RV, O'Donnell M, Share D et al. Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073
41. Marenzi G, Assanelli E, Campodonico J et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2003; 150: 170-177
42. Mager A, Vaknin Assa H, Lev EI et al. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv 2010; 78: 198-201.
43. Gurm HS, Dixon SR, Smith DE et al. BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58: 907-914
44. Yoon HJ, Hur SH. Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrastinduced nephropathy after elective percutaneous coronary intervention. Korean Circ J 2011; 41: 265-271
45. Nyman U, Björk J, Aspelin P et al. Contrast medium dose-to- GFR ratio: a measure of systemic exposure to predict contrastinduced nephropathy after percutaneous coronary intervention. Acta Radiol 2008; 49: 658-667
46. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999; 9: 1602-1613
47. McCullough PA, Sandberg KR. Epidemiology of contrastinduced nephropathy. Rev Cardiovasc Med 2003;4(Suppl 5): S3-S9